KALA BIO shares surge 28.1% after-hours after issuing 4.2M shares to settle $10.6M in debts and execute multi-party agreements with Baker Bros. Advisors and LifeSci Capital.

KALA BIO surged 28.10% in after-hours trading following the announcement of multiple agreements to resolve financial obligations and align governance. The company settled claims with Baker Bros. Advisors and LifeSci Capital by issuing 3.1 million shares, eliminating $10.6 million in liabilities. A separate Voting Agreement with Baker Bros. secured proxy voting control for six months, enhancing governance clarity. Additionally, KALA BIO settled a $600,000 consulting fee with Delaware IR via 1.1 million shares, preserving cash. These equity-driven resolutions addressed debt overhang, reduced litigation risks, and stabilized stakeholder alignment, likely driving the sharp after-hours rally.